lipid metabolic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
phospholipid metabolic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
apoptotic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
negative regulation of cell population proliferation | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
positive regulation of macrophage derived foam cell differentiation | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
arachidonic acid metabolic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
negative regulation of cell migration | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
prostate gland development | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
regulation of epithelial cell differentiation | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
positive regulation of chemokine production | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
positive regulation of peroxisome proliferator activated receptor signaling pathway | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
positive regulation of keratinocyte differentiation | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
negative regulation of cell cycle | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
negative regulation of growth | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
hepoxilin biosynthetic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
endocannabinoid signaling pathway | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
cannabinoid biosynthetic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
lipoxin A4 biosynthetic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
linoleic acid metabolic process | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
lipid oxidation | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
lipoxygenase pathway | Polyunsaturated fatty acid lipoxygenase ALOX15B | Homo sapiens (human) |
calcium ion homeostasis | Alpha-synuclein | Homo sapiens (human) |
negative regulation of transcription by RNA polymerase II | Alpha-synuclein | Homo sapiens (human) |
microglial cell activation | Alpha-synuclein | Homo sapiens (human) |
positive regulation of receptor recycling | Alpha-synuclein | Homo sapiens (human) |
positive regulation of neurotransmitter secretion | Alpha-synuclein | Homo sapiens (human) |
negative regulation of protein kinase activity | Alpha-synuclein | Homo sapiens (human) |
fatty acid metabolic process | Alpha-synuclein | Homo sapiens (human) |
neutral lipid metabolic process | Alpha-synuclein | Homo sapiens (human) |
phospholipid metabolic process | Alpha-synuclein | Homo sapiens (human) |
activation of cysteine-type endopeptidase activity involved in apoptotic process | Alpha-synuclein | Homo sapiens (human) |
mitochondrial membrane organization | Alpha-synuclein | Homo sapiens (human) |
adult locomotory behavior | Alpha-synuclein | Homo sapiens (human) |
response to xenobiotic stimulus | Alpha-synuclein | Homo sapiens (human) |
response to iron(II) ion | Alpha-synuclein | Homo sapiens (human) |
regulation of phospholipase activity | Alpha-synuclein | Homo sapiens (human) |
negative regulation of platelet-derived growth factor receptor signaling pathway | Alpha-synuclein | Homo sapiens (human) |
regulation of glutamate secretion | Alpha-synuclein | Homo sapiens (human) |
regulation of dopamine secretion | Alpha-synuclein | Homo sapiens (human) |
synaptic vesicle exocytosis | Alpha-synuclein | Homo sapiens (human) |
synaptic vesicle priming | Alpha-synuclein | Homo sapiens (human) |
regulation of transmembrane transporter activity | Alpha-synuclein | Homo sapiens (human) |
negative regulation of microtubule polymerization | Alpha-synuclein | Homo sapiens (human) |
receptor internalization | Alpha-synuclein | Homo sapiens (human) |
protein destabilization | Alpha-synuclein | Homo sapiens (human) |
response to magnesium ion | Alpha-synuclein | Homo sapiens (human) |
negative regulation of transporter activity | Alpha-synuclein | Homo sapiens (human) |
response to lipopolysaccharide | Alpha-synuclein | Homo sapiens (human) |
negative regulation of monooxygenase activity | Alpha-synuclein | Homo sapiens (human) |
positive regulation of peptidyl-serine phosphorylation | Alpha-synuclein | Homo sapiens (human) |
response to type II interferon | Alpha-synuclein | Homo sapiens (human) |
cellular response to oxidative stress | Alpha-synuclein | Homo sapiens (human) |
SNARE complex assembly | Alpha-synuclein | Homo sapiens (human) |
positive regulation of SNARE complex assembly | Alpha-synuclein | Homo sapiens (human) |
regulation of locomotion | Alpha-synuclein | Homo sapiens (human) |
dopamine biosynthetic process | Alpha-synuclein | Homo sapiens (human) |
mitochondrial ATP synthesis coupled electron transport | Alpha-synuclein | Homo sapiens (human) |
regulation of macrophage activation | Alpha-synuclein | Homo sapiens (human) |
positive regulation of apoptotic process | Alpha-synuclein | Homo sapiens (human) |
negative regulation of apoptotic process | Alpha-synuclein | Homo sapiens (human) |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | Alpha-synuclein | Homo sapiens (human) |
negative regulation of neuron apoptotic process | Alpha-synuclein | Homo sapiens (human) |
positive regulation of endocytosis | Alpha-synuclein | Homo sapiens (human) |
negative regulation of exocytosis | Alpha-synuclein | Homo sapiens (human) |
positive regulation of exocytosis | Alpha-synuclein | Homo sapiens (human) |
regulation of long-term neuronal synaptic plasticity | Alpha-synuclein | Homo sapiens (human) |
synaptic vesicle endocytosis | Alpha-synuclein | Homo sapiens (human) |
synaptic vesicle transport | Alpha-synuclein | Homo sapiens (human) |
positive regulation of inflammatory response | Alpha-synuclein | Homo sapiens (human) |
regulation of acyl-CoA biosynthetic process | Alpha-synuclein | Homo sapiens (human) |
protein tetramerization | Alpha-synuclein | Homo sapiens (human) |
positive regulation of release of sequestered calcium ion into cytosol | Alpha-synuclein | Homo sapiens (human) |
neuron apoptotic process | Alpha-synuclein | Homo sapiens (human) |
dopamine uptake involved in synaptic transmission | Alpha-synuclein | Homo sapiens (human) |
negative regulation of dopamine uptake involved in synaptic transmission | Alpha-synuclein | Homo sapiens (human) |
negative regulation of serotonin uptake | Alpha-synuclein | Homo sapiens (human) |
regulation of norepinephrine uptake | Alpha-synuclein | Homo sapiens (human) |
negative regulation of norepinephrine uptake | Alpha-synuclein | Homo sapiens (human) |
excitatory postsynaptic potential | Alpha-synuclein | Homo sapiens (human) |
long-term synaptic potentiation | Alpha-synuclein | Homo sapiens (human) |
positive regulation of inositol phosphate biosynthetic process | Alpha-synuclein | Homo sapiens (human) |
negative regulation of thrombin-activated receptor signaling pathway | Alpha-synuclein | Homo sapiens (human) |
response to interleukin-1 | Alpha-synuclein | Homo sapiens (human) |
cellular response to copper ion | Alpha-synuclein | Homo sapiens (human) |
cellular response to epinephrine stimulus | Alpha-synuclein | Homo sapiens (human) |
positive regulation of protein serine/threonine kinase activity | Alpha-synuclein | Homo sapiens (human) |
supramolecular fiber organization | Alpha-synuclein | Homo sapiens (human) |
negative regulation of mitochondrial electron transport, NADH to ubiquinone | Alpha-synuclein | Homo sapiens (human) |
positive regulation of glutathione peroxidase activity | Alpha-synuclein | Homo sapiens (human) |
positive regulation of hydrogen peroxide catabolic process | Alpha-synuclein | Homo sapiens (human) |
regulation of synaptic vesicle recycling | Alpha-synuclein | Homo sapiens (human) |
regulation of reactive oxygen species biosynthetic process | Alpha-synuclein | Homo sapiens (human) |
positive regulation of protein localization to cell periphery | Alpha-synuclein | Homo sapiens (human) |
negative regulation of chaperone-mediated autophagy | Alpha-synuclein | Homo sapiens (human) |
regulation of presynapse assembly | Alpha-synuclein | Homo sapiens (human) |
amyloid fibril formation | Alpha-synuclein | Homo sapiens (human) |
synapse organization | Alpha-synuclein | Homo sapiens (human) |
chemical synaptic transmission | Alpha-synuclein | Homo sapiens (human) |
negative regulation of inflammatory response to antigenic stimulus | Guanine nucleotide-binding protein G | Homo sapiens (human) |
renal water homeostasis | Guanine nucleotide-binding protein G | Homo sapiens (human) |
G protein-coupled receptor signaling pathway | Guanine nucleotide-binding protein G | Homo sapiens (human) |
regulation of insulin secretion | Guanine nucleotide-binding protein G | Homo sapiens (human) |
cellular response to glucagon stimulus | Guanine nucleotide-binding protein G | Homo sapiens (human) |
positive regulation of epidermal growth factor receptor signaling pathway | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
response to hypoxia | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
neutrophil mediated immunity | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
germinal center formation | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of leukocyte chemotaxis | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
proteolysis | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
membrane protein ectodomain proteolysis | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
cell adhesion | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
Notch receptor processing | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of cell population proliferation | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
response to xenobiotic stimulus | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of T cell chemotaxis | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
protein processing | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
signal release | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
B cell differentiation | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of cell growth | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of cell migration | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
negative regulation of transforming growth factor beta receptor signaling pathway | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
response to lipopolysaccharide | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of chemokine production | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of tumor necrosis factor production | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
regulation of mast cell apoptotic process | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
T cell differentiation in thymus | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
cell adhesion mediated by integrin | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
wound healing, spreading of epidermal cells | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
amyloid precursor protein catabolic process | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of blood vessel endothelial cell migration | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of cyclin-dependent protein serine/threonine kinase activity | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of epidermal growth factor-activated receptor activity | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of epidermal growth factor receptor signaling pathway | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
spleen development | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
cell motility | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
defense response to Gram-positive bacterium | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
cellular response to high density lipoprotein particle stimulus | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
commissural neuron axon guidance | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
negative regulation of cold-induced thermogenesis | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of G1/S transition of mitotic cell cycle | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of tumor necrosis factor-mediated signaling pathway | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
positive regulation of vascular endothelial cell proliferation | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
Notch signaling pathway | Disintegrin and metalloproteinase domain-containing protein 17 | Homo sapiens (human) |
negative regulation of protein phosphorylation | TAR DNA-binding protein 43 | Homo sapiens (human) |
mRNA processing | TAR DNA-binding protein 43 | Homo sapiens (human) |
RNA splicing | TAR DNA-binding protein 43 | Homo sapiens (human) |
negative regulation of gene expression | TAR DNA-binding protein 43 | Homo sapiens (human) |
regulation of protein stability | TAR DNA-binding protein 43 | Homo sapiens (human) |
positive regulation of insulin secretion | TAR DNA-binding protein 43 | Homo sapiens (human) |
response to endoplasmic reticulum stress | TAR DNA-binding protein 43 | Homo sapiens (human) |
positive regulation of protein import into nucleus | TAR DNA-binding protein 43 | Homo sapiens (human) |
regulation of circadian rhythm | TAR DNA-binding protein 43 | Homo sapiens (human) |
regulation of apoptotic process | TAR DNA-binding protein 43 | Homo sapiens (human) |
negative regulation by host of viral transcription | TAR DNA-binding protein 43 | Homo sapiens (human) |
rhythmic process | TAR DNA-binding protein 43 | Homo sapiens (human) |
regulation of cell cycle | TAR DNA-binding protein 43 | Homo sapiens (human) |
3'-UTR-mediated mRNA destabilization | TAR DNA-binding protein 43 | Homo sapiens (human) |
3'-UTR-mediated mRNA stabilization | TAR DNA-binding protein 43 | Homo sapiens (human) |
nuclear inner membrane organization | TAR DNA-binding protein 43 | Homo sapiens (human) |
amyloid fibril formation | TAR DNA-binding protein 43 | Homo sapiens (human) |
regulation of gene expression | TAR DNA-binding protein 43 | Homo sapiens (human) |
[Information is prepared from geneontology information from the June-17-2024 release] |